Scintillation camera imaging is used for treatment planning and post-treatment dosimetry in liver radioembolization (RE). In yttrium-90 (90Y) RE, scintigraphic images of technetium-99m (99mTc) are used for treatment planning, while 90Y Bremsstrahlung images are used for post-treatment dosimetry. In holmium-166 (166Ho) RE, scintigraphic images of 166Ho can be used for both treatment planning and post-treatment dosimetry. The aim of this study is to quantitatively evaluate and compare the imaging characteristics of these three isotopes, in order that imaging protocols can be optimized and RE studies with varying isotopes can be compared.
Phantom experiments were performed in line with NEMA guidelines to assess the spatial resolution, sensitivity, count rate linearity, and contrast recovery of 99mTc, 90Y and 166Ho. In addition, Monte Carlo simulations were performed to obtain detailed information about the history of detected photons. The results showed that the use of a broad energy window and the high-energy collimator gave optimal combination of sensitivity, spatial resolution, and primary photon fraction for 90Y Bremsstrahlung imaging, although differences with the medium-energy collimator were small. For 166Ho, the high-energy collimator also slightly outperformed the medium-energy collimator. In comparison with 99mTc, the image quality of both 90Y and 166Ho is degraded by a lower spatial resolution, a lower sensitivity, and larger scatter and collimator penetration fractions.
Citation: Elschot M, Nijsen JFW, Dam AJ, de Jong HWAM (2011) Quantitative Evaluation of Scintillation Camera Imaging Characteristics of Isotopes Used in Liver Radioembolization. PLoS ONE6(11): e26174. https://doi.org/10.1371/journal.pone.0026174
Editor: C. Andrew Boswell, Genentech, United States of America
Received: August 24, 2011; Accepted: September 21, 2011; Published: November 3, 2011
Copyright: © 2011 Elschot et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work received funding from the University Medical Center Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Intra-arterial liver radioembolization (RE) using microspheres loaded with a high-energy beta emitting isotope, is an emerging technique for radiation treatment of patients with unresectable liver tumors , . RE leads to high tumor absorbed radiation doses, while the surrounding healthy liver tissue is spared . RE is generally a two-step procedure, consisting of i) the administration of a small amount of activity, the scout dose, and ii) subsequent administration of the activity that is expected to have a therapeutic effect, the therapy dose. The spatial distribution of the scout dose is expected to represent the distribution of the therapy dose, and can consequently be used to predict safety of the procedure.
The spatial distribution of the scout and therapy dose is commonly assessed using scintillation camera imaging. Following administration of the scout dose, the patient undergoes single photon emission computed tomography (SPECT) to detect extrahepatic deposition of activity, which is a contra-indication for therapy, and planar scintillation camera imaging to determine the percentage of activity that shunted to the lungs. A high lung-shunting (LS) percentage provokes reduction of the therapy dose (10%<LS<20% (SIR-Spheres package insert; Sirtex Medical, Sydney, Australia)) or even cancellation of therapy (LS>20%). After treatment, a SPECT scan of the therapy dose is usually acquired to confirm absence of extrahepatic activity. This scan can also be used to retrospectively assess a dose-response relation.
The beta-emitter yttrium-90 (90Y, Table 1) is most frequently used for RE. Its distribution can be assessed by means of SPECT imaging of the Bremsstrahlung photons –. Unfortunately, the continuous Bremsstrahlung energy spectrum comprises photon energies ranging up to 2 MeV, and is therefore associated with poor image quality . For this reason, Technetium-99m-labeled macroaggregated albumin particles (99mTc-MAA) are generally used for the scout dose, as a substitute for the 90Y microspheres, since the image quality is much better , . The 99mTc-MAA particles, however, differ in shape, size, density and quantity from the 90Y microspheres, potentially affecting the spatial distribution of the scout dose , . Furthermore, the instability of 99mTc-MAA particles frequently leads to uptake of dissociated 99mTc-pertechnetate in the thyroid and gastrointestinal tract , and to shunting of smaller and disintegrated particles to the lungs , which altogether may cause false adjustment of the 90Y therapy dose. As a potential alternative to 90Y microspheres, holmium-166 (166Ho, Table 1) loaded microspheres are currently investigated in a clinical study –. The higher specific activity and shorter half life may have a beneficial impact on tumor kill. Additionally, the imaging characteristics of 166Ho are believed to be more suitable for quantitative imaging than 90Y, because it is a combined beta-gamma emitter , . 166Ho microspheres may conceivably be used for both the scout dose and the therapy dose, which potentially improves the predictive value of the scout dose distribution and post-therapy liver dosimetry.
Scintillation camera images of 99mTc, 90Y, and 166Ho are all used for clinical assessment of the activity distribution in liver RE, but they have differing imaging characteristics. In contrast to 99mTc, information on the scintillation camera imaging characteristics of 90Y and 166Ho is sparse, and a systematical comparison between these three isotopes does not exist. Therefore, the aim of this study is to provide a systematical evaluation and comparison of the scintillation camera imaging characteristics of 90Y, 166Ho and 99mTc, using a series of phantom experiments and Monte Carlo simulations. This is important for (future) clinical comparisons between microsphere RE studies with varying isotopes and imaging protocols. In addition, the outcome of this study can be used to optimize the acquisition settings for 90Y and 166Ho imaging, and to guide future developments in SPECT image reconstruction.
Materials and Methods
The spatial resolution, sensitivity, count rate linearity, and contrast recovery of 99mTc, 90Y, and 166Ho were evaluated by means of phantom experiments. If possible, the well-defined National Electrical Manufacturers Association (NEMA) 2007 guidelines were adopted, facilitating (future) comparison with other isotopes and acquisition protocols , . In addition, Monte Carlo simulations were performed to yield data that cannot be retrieved from physical experiments, including the fractions of primary photons, scattered photons, and collimator-penetrated photons of the line source measurements.
Data was acquired with a Philips FORTE™ dual-headed camera with 3/8 inch thick thallium-doped sodium-iodide (NaI(Tl)) crystals. 99mTc measurements were performed with the low-energy general purpose (VXGP) collimator. Medium-energy (MEGP) and high-energy general purpose (HEGP) collimators were mounted for the 90Y and 166Ho measurements, to reduce collimator penetration of high-energy photons. The energy window settings for 90Y Bremsstrahlung imaging vary between institutions, ranging from small windows with a relatively low central energy , , to intermediate ,  and broad energy windows , , –. Although it is generally believed that a wide energy window is required to maintain sufficient sensitivity, no consensus exists on the optimal central energy and window width. Therefore, both a broad 50–250 keV window, which optimizes sensitivity, and a smaller 120–250 keV window, which is expected to have less scatter contamination, were evaluated in this study. The used energy window settings and collimator characteristics are listed in Table 1 and 2, respectively.
Spatial resolution defines whether small accumulations of activity, e.g. in or around tumors, can be detected and quantified. Projection images (matrix = 256×256, pixelsize = 2.332×2.332 mm2) of a 28 cm long line source with an inner diameter of 2 mm were acquired. To create realistic conditions with regard to electron absorption, and (Bremsstrahlung) photon emission and scatter, the line source was centered in 2, 10, and 20 cm of poly(methyl methacrylate) (PMMA), leading to 1, 5, and 10 cm of scatter material below and on top of the source. Measurements were performed with a source to collimator distance of 2, 6 and 11 cm for 1 cm of scatter material and 11 cm for the measurements with 5 and 10 cm of scatter material (Figure 1). The central lines perpendicular to the source were summed over a distance of 10 cm to obtain the line spread function (LSF). The full width at half maximum (FWHM) and the full width at tenth maximum (FWTM) of the LSF were determined according to NEMA guidelines.
The imaging sensitivity of an isotope is directly related to the image noise, which can be important for detection of small amounts of extrahepatic activity. As described by NEMA, a Petri dish was filled with a thin layer of activity, which was beforehand measured with a calibrated dose calibrator. The dish was placed in the center of the field-of-view of the camera, at a distance of 10 cm and 40 cm from the collimator. To ensure stopping all electrons and proper creation of the Bremsstrahlung photons, 1 cm thick PMMA slabs were placed below and on top of the dish for the 90Y and 166Ho sensitivity measurements. In each measurement, 4 million counts were acquired. The sensitivity (S) [cps Mbq−1] was calculated as the total number of counts in the field-of-view, divided by acquisition time times activity.
To enable calculation of the system count-rate linearity, described in the next section, the sensitivity measurements were simultaneously acquired in two energy windows: the regular photopeak energy window, and an energy window covering the complete energy range of the camera (‘full-energy-window’).
Count rate linearity.
In RE, therapy doses up to several GBqs are typically administered to the patient. These high activities can lead to detector dead-time and, consequently, to underestimation of the dose. This effect is described by the system count rate curve, that depends on i) the system sensitivity, which is determined by the number of photons that pass the collimator and fall within the energy window, and ii) the dead-time, which depends on the total number of photons that hit the crystal. The first can be measured as described in the ‘sensitivity’ section. The latter is theoretically described by Sorensen's count rate model for paralyzable scintillation cameras  and can be provided by the intrinsic count rate measurements described here.
Cylindrical vials with an inner diameter of 2.4 cm were filled with the isotopes solved in 11 ml water. Activities ranged from 0.5–24.5 MBq for 99mTc, 16.9–350.8 MBq for 90Y and 5.0–121.1 MBq for 166Ho, to include count rates from the linear range to count rates that cause dead-time effects. The vials were placed in the center of the field-of-view of the camera, at 66.5 cm from the detector, resulting in a uniform photon flux on the detector. The acquisition time was 10 minutes and the energy window was set to the full-energy-window, yielding an intrinsic count rate [cps] comprised of all photons that hit the detector.
From the intrinsic count rate curve (measured in the full-energy-window), the system sensitivity in the full-energy-window, and the system sensitivity in the photopeak window, the system count rate in the photopeak window can be calculated for each isotope and collimator and plotted as a function of activity. The reported maximum activity with linear count rate response (Alinmax) was defined as the highest activity with less than 2% loss of count rate. The corresponding maximum achievable linear count rate (Rlinmax) was also reported.
Contrast recovery is important if quantification of local accumulation of activity is required, as is the case with image based tumor dosimetry in RE. Contrast recovery was determined using a fillable torso-shaped NEMA image quality phantom (volume = 9700 ml) containing six fillable coplanar spheres (inner diameter = 10, 13, 17, 22, 28, and 37 mm). Lung tissue was simulated by a central cylindrical lung insert. The phantom background activity concentrations and SPECT scan times were matched to obtain the total number of counts corresponding to a 30 minutes SPECT scan with clinically realistic liver activity concentrations: 137 kBq ml−1, 573 kBq ml−1, and 166 kBq ml−1, for 99mTc, 90Y, and 166Ho, respectively, and a sphere-to-background activity concentration ratio (R) of 9∶1. These activity concentrations were based on a scout dose for 99mTc and166Ho, and a therapy dose for 90Y. SPECT data was acquired in 120 projections over a 360° orbit. Volumes were reconstructed using filtered back-projection (FBP), on a 128×128×128 grid with an isotropic voxel size of 4.664 mm. No additional filtering other than the ramp filter was applied. Post-reconstruction, images were corrected for attenuation using the Chang algorithm with a non-uniform effective broad beam linear attenuation coefficient. Contrast recovery coefficients (QH) were calculated in accordance with NEMA guidelines. An example of the filled phantom with hot sphere and background regions of interest (ROI) is given in Figure 2.
The slice through the center of the spheres of the contrast recovery phantom filled with 99mTc is shown. Overlaid are the locations of the lung insert (central red ROI), the hot sphere ROI (peripheral red ROI), and 11 of the 55 background ROI of the largest sphere (green ROI).
Monte Carlo simulations
Monte Carlo simulations were performed with the well validated general purpose Monte Carlo radiation transport code mcnpx 2.5.0 . The camera head was modeled realistically including collimator housing, collimator, aluminum crystal housing, NaI(Tl) crystal, 5 cm of crown glass mimicking the backscatter compartments, and lead shielding. Both gamma photon (for 99mTc and 166Ho) and Bremsstrahlung photon (for 90Y and 166Ho) contributions were simulated. The mono-energetic gamma photons were simulated weighted by their relative abundance as given in Table 1. Only 2.0% of the 90Y and 1.2% of the 166Ho beta emissions lead to Bremsstrahlung photons with an energy higher than 50 keV. Therefore, the Bremsstrahlung photons were sampled from a predefined energy spectrum and source distribution, similar to the approach published by Rault et al , which improved the efficiency of the simulations substantially.
Primary, scatter, and penetration fraction.
Monte Carlo simulations were performed to estimate the fractions of primary (PF), scattered (SF) and collimator-penetrated (CPF) photons. Since high SF and CPF have deteriorating effects on the image quality, their characterizations give insight into the effectiveness of the chosen collimator and energy window. The geometry of the simulations was equal to the geometry of measurements of the line source centered in 20 cm PMMA, shown in Figure 1. A detected photon was defined as a photon that deposited at least part of its energy in the crystal, sub-divided in three groups:
- Primary photons: detected photons that did not interact with material or penetrate through the collimator.
- Scattered photons: detected photons that scattered in the PMMA, photons that scattered in the camera-housing or detector, and photons that were created in the collimator (lead x-rays). None of these photons penetrated the collimator.
- Penetrated photons: all detected photons (unscattered or scattered) that penetrated through the collimator.
The number of photons released was 300 million for both gamma photon and Bremsstrahlung photon simulations. Equal to the spatial resolution measurements, the central lines perpendicular to the source were summed over a distance of 10 cm to obtain the LSF. The total 166Ho LSF was calculated as the abundance weighted summation of gamma and Bremsstrahlung photon contributions. The experimental and simulated LSF measurements were compared visually.
Table 3 lists the FWHM and FWTM in mm of the measured LSF for the three isotopes. In both energy windows, the 90Y LSF showed smaller FWHM and FWTM for the HEGP than for the MEGP collimator. The FWHM were slightly smaller for the 120–250 keV window than for the 50–250 keV window, but the FWTM were substantially larger. For 166Ho, the HEGP collimator yielded a higher resolution than the MEGP collimator, as can be appreciated by the slightly smaller FWHM, and substantially smaller FWTM, for all measurements.
The planar sensitivities, measured at a distance of 10 and 40 cm from the collimator face, are listed in Table 4. As was expected from the photon abundances, the 99mTc sensitivity was higher than the 166Ho sensitivity. The 90Y sensitivity was lower than 166Ho sensitivity for both energy windows. No difference was observed between the 99mTc sensitivities at 10 cm and 40 cm, indicating proper collimation of the photons. To the contrary, the sensitivity for both 90Y and 166Ho decreased at a larger distance from the collimator, due to collimator penetration effects. This effect was larger for the MEGP collimator than for the HEGP collimator.
Count rate linearity.
Figure 3A shows the observed intrinsic count rate as a function of the ideal count rate for all isotopes. As expected, this intrinsic count rate curve did not depend on the isotope imaged and was fitted well by Sorensen's count rate model of paralyzable scintillation cameras . Figure 3B shows the system count rate curves for all isotopes and measurement settings, estimated from the intrinsic count rate curve and the system sensitivities. Alinmax and Rlinmax are listed in Table 5. The Alinmax of approximately 1.5 GBq for 166Ho might be a limitation for scintillation camera imaging directly after treatment. The quantitative accuracy of imaging the 99mTc-MAA scout dose (∼150 MBq), 166Ho scout dose (∼250 MBq), and 90Y therapy dose (∼1–3 GBq) in the clinical range will not be affected by dead-time effects.
(A) The observed count rate is plotted as a function of ideal count rate. Sorensen's count rate model for paralyzable cameras (solid line) is fitted to the intrinsic count rate measurements (data points). The ideal camera count rate response, without dead-time effects, is plotted by the dashed line. (B) Shown are the system count rate curves (solid lines), composed of the intrinsic count rate linearity curve and the system sensitivity measurements. The slope of the ideal system camera count rate response (dashed lines) corresponds to the system sensitivity.
Figure 4 shows the slice through the centers of the spheres of all FBP reconstructed images. In Figure 5, contrast recovery coefficients are shown as a function of sphere diameter. The 99mTc contrast recovery was 59% for the largest sphere. For 90Y and 166Ho, this was 17% and 35%, respectively. Neither collimator choice, nor energy window choice affected the 90Y contrast recovery much. Also, no difference was observed between the MEGP and HEGP 166Ho contrast recovery curves.
The slices through the center of the spheres of the contrast recovery phantom are shown for 99mTc and VXGP (A), 90Y 120–250 keV and MEGP (B), 90Y 120–250 keV and HEGP (C), 90Y 50–250 keV and MEGP (D), 90Y 50–250 keV and HEGP (E), 166Ho and MEGP (F), and 166Ho and HEGP (G). All images were linearly window-leveled from 0 to 4 times the average background intensity.
Monte Carlo simulations
Primary, scatter, and penetration fraction.
The measured and simulated LSF of the line source centered in 20 cm PMMA are shown in Figure 6. The good agreement between both the center and the tails confirms the accuracy of the Monte Carlo simulations. The simulated LSF were subdivided in the three different photon classification groups. Table 6 lists the PF, SF and CPF of each isotope. For both 90Y and 166Ho, the HEGP collimator yielded a higher PF than the MEGP collimator, due to reduction of the number of penetrated photons. PF was similar for 90Y measured in the 120–250 keV window and in the 50–250 keV energy window, but the first was more contaminated by septal penetration, and the latter more by scatter. The 166Ho LSF was more contaminated by septal penetration than by scatter.
(A) LSF of the 99mTc line-source and VXGP collimator, (B) 166Ho and HEGP, (C) 90Y 120–250 keV and HEGP, and (D) 90Y 50–250 keV and MEGP. Data is plotted on semi-logarithmic scale, showing good agreement between the measurements (data points) and simulations (blue solid line). The intensity is normalized to the total number of counts in the ROI. Contributions of primary, scattered, and penetrated photons are shown in green, light blue, and red, respectively.
The scintillation camera imaging characteristics of three isotopes used in RE were quantitatively evaluated with phantom experiments and Monte Carlo simulations. Although the superiority of 99mTc was expected, its characteristics are valuable in evaluation of and comparison to the other two isotopes.
NEMA prescribes assessment of spatial resolution by means of point source measurements, but the more practical approach of the line source was chosen in this work. Nonetheless, good agreement between the FWHM presented here and in the literature was found for all isotopes. The measured FWHM of 99mTc appeared to be slightly larger than that given in the specifications of the camera manufacturer (8.2 mm and 7.8 mm, respectively). This difference might be due to the measurement set-up with the source behind 1 cm PMMA. Indeed, measurement of the 99mTc line source in air (data not shown) yielded a FWHM of 7.7 mm. The set-up was chosen, however, to be in line with 90Y and 166Ho measurements, which need the scatter material around the source to create all Bremsstrahlung photons. The spatial resolution of the 90Y LSF was in good agreement with results of previous studies, despite small differences in measurement settings. Shen et al reported a FWHM of 12.5 mm for a point source placed behind 1.8 cm of lucite, a source to detector (HEGP collimator) distance of 6.8 cm and an energy window of 55–285 keV , which is in good agreement with the FWHM of 11.4 mm found in this study for the line source behind 1 cm PMMA, a source to detector distance of 6 cm, and an energy window of 50–250 keV. Interestingly, the FWHM of the 120–250 keV window was slightly smaller than the 50–250 keV window, whereas the FWTM was substantially larger. This effect can be explained by the higher (collimator) scatter fraction in the 50–250 keV window, which broadened the FWHM, and the larger amount of collimator penetration in the 120–250 window, which caused a large FWTM. The spatial resolution of 166Ho was investigated by Bayouth and Macey, reporting a FWHM of approximately 16 mm of a line source measured behind 12 cm of scatter material , which is in good agreement with the FWHM of 15.6 mm of the 166Ho line source behind 10 cm PMMA (HEGP, collimator distance 11 cm) found in this study.
The 90Y planar system sensitivity was similar to earlier reports . The sensitivity found for 166Ho was higher than the window-based, non-primary subtraction corrected sensitivity reported by Bayouth and Macey . Good agreement was found if taking into account that about half of the detected photons of this study are non-primary, as was estimated from Monte Carlo simulations. The MEGP collimator showed a higher planar sensitivity than the HEGP collimator for both 90Y and 166Ho. However, Monte Carlo simulations elucidated higher primary fractions for the HEGP than for the MEGP collimator (Table 6). Monte Carlo simulations also revealed that 90Y and 166Ho non-primary photons lack spatial information, as is illustrated in Figure 6. Taking this into account, the useable sensitivity of the HEGP collimator, i.e. the sensitivity for primary photons, is similar to that of the MEGP collimator. With similar number of primary photons, and less background signal due to penetrated photons, the HEGP is preferred over the MEGP collimator for both 90Y and 166Ho.
The contrast recovery SPECT data was reconstructed using FBP, without inclusion of collimator modeling and scatter correction techniques. Compared to (model-based) iterative reconstruction algorithms, the FBP approach will result in suboptimal contrast recovery, but the first requires parameters that need to be optimized and have a large effect on image quality, such as the number of iterations. Reasonably accurate model-based quantitative image reconstruction methods have been proposed for both 166Ho and 90Y , , but these have distinct underlying algorithms, which makes straight-forward comparison of the isotope performance difficult. The FBP reconstructed contrast recovery coefficients reported in this study should not be interpreted as a measure of maximum isotope performance, but as a measure of isotope performance relative to each other. Since contrast recovery depends on resolution, scatter and penetration, it can be interpreted as a quantitative measure of overall image quality. This image quality of 99mTc is higher than the 166Ho image quality, which in turn is higher than that of 90Y (Figure 5). No differences in 90Y contrast recovery were observed between energy windows and collimators. Although the HEGP collimator demonstrated a higher spatial resolutions and higher primary photon fraction than the MEGP collimator, differences were potentially too subtle to cause a substantial gain in contrast recovery in the FBP reconstructed images. Likewise, the 166Ho contrast recovery curves did not show differences between the MEGP and HEGP collimators. From Figure 4, however, it can be appreciated that the perceptual 90Y image quality is substantially better in the 50–250 keV energy window than the 120–250 keV energy window, due to reduction of the image noise. It can therefore be postulated that the use of a broad energy window and a HEGP collimator gave the optimal combination of sensitivity, spatial resolution and primary photon fraction for 90Y imaging, although differences with the MEGP collimator were small. The HEGP collimator also slightly outperformed the MEGP collimator in the 166Ho experiments.
The Monte Carlo simulations provided valuable information on the contribution and spatial distribution of different classes of photons, which could not be obtained by performing measurements alone. As is illustrated in Figure 6, there is a fundamental difference between the penetrated photons of 99mTc and those of 90Y and 166Ho. Collimator penetration of 99mTc photons is dominated by photons that slightly graze the septum edge. These photons maintain their spatial information. On the contrary, collimator penetration of 90Y and 166Ho is dominated by high-energy photons that, after penetration, scatter in the crystal or backscatter in the camera. These photons lack spatial information and degrade the image quality. Also, from Figure 6 it can be appreciated that photon scatter is the main source of degradation of 90Y image quality in the 50–250 keV energy window, and collimator penetration in the 120–250 keV energy window.
The results presented in this paper suggest that accurate scatter and collimator penetration correction techniques could greatly enhance the quantitative accuracy of 90Y and 166Ho scintillation camera imaging. Quantitative accuracies of 99mTc SPECT with optimized correction techniques are typically within 5% for phantom studies and within 10% for clinical studies –. Reasonably accurate distribution estimates in phantoms have already been reported for 166Ho SPECT by de Wit et al.  and for 90Y by Minarik et al. . The quantitative accuracy of 99mTc SPECT might be approached if these correction schemes are further improved, which is important for accurate assessment of the distribution of the scout dose, determination of the lung-shunting fraction, and post-therapy liver dosimetry in radioembolization.
Besides scintillation camera imaging, other imaging modalities may also allow for quantitative assessment of the microsphere distribution in radioembolization. Recently, Positron Emission Tomography (PET) was proposed to image the 90Y therapy dose distribution – and phantom experiments have demonstrated the feasibility of quantitative imaging of the distribution of (non-radioactive) holmium with magnetic resonance imaging (MRI) , , . Although both 90Y PET and holmium MRI have intrinsically promising imaging characteristics, such as a high spatial resolution, the clinical value of these modalities in microsphere radioembolization is yet unknown and subject of ongoing research.
In this study, the scintillation camera imaging characteristics of three isotopes used in radioembolization were quantitatively evaluated and compared. The use of a broad energy window and HEGP collimator gave optimal combination of sensitivity, spatial resolution, and primary photon fraction for 90Y Bremsstrahlung imaging, although differences with the MEGP collimator were small. For 166Ho imaging, the HEGP collimator slightly outperformed the MEGP. The image quality of both 90Y and 166Ho was affected more by partial volume effects, scatter, and collimator penetration than that of 99mTc. The detailed breakdown of these imaging characteristics can help to direct the optimization of acquisition protocols and quantitative reconstruction algorithms for 90Y and 166Ho SPECT. The characterization of the three isotopes can guide future comparisons between or within clinical radioembolization studies with varying isotopes and imaging protocols.
Conceived and designed the experiments: ME JFWN HWAMdJ. Performed the experiments: ME AJD HWAMdJ. Analyzed the data: ME HWAMdJ. Contributed reagents/materials/analysis tools: JFWN. Wrote the paper: ME JFWN AJD HWAMdJ.
- 1. Kennedy AS, Salem R (2010) Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies. Cancer J 16: 163–175.AS KennedyR. Salem2010Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies.Cancer J16163175
- 2. Vente MA, Wondergem M, van der Tweel I, van den Bosch MA, Zonnenberg BA, et al. (2009) Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol 19: 951–959.MA VenteM. WondergemI. van der TweelMA van den BoschBA Zonnenberg2009Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis.Eur Radiol19951959
- 3. Gulec SA, Fong Y (2007) Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases. Arch Surg 142: 675–682.SA GulecY. Fong2007Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases.Arch Surg142675682
- 4. Fabbri C, Sarti G, Cremonesi M, Ferrari M, Di DA, et al. (2009) Quantitative analysis of 90Y Bremsstrahlung SPECT-CT images for application to 3D patient-specific dosimetry. Cancer Biother Radiopharm 24: 145–154.C. FabbriG. SartiM. CremonesiM. FerrariDA Di2009Quantitative analysis of 90Y Bremsstrahlung SPECT-CT images for application to 3D patient-specific dosimetry.Cancer Biother Radiopharm24145154
- 5. Minarik D, Sjogreen GK, Ljungberg M (2008) Evaluation of quantitative (90)Y SPECT based on experimental phantom studies. Phys Med Biol 53: 5689–5703.D. MinarikGK SjogreenM. Ljungberg2008Evaluation of quantitative (90)Y SPECT based on experimental phantom studies.Phys Med Biol5356895703
- 6. Minarik D, Ljungberg M, Segars P, Gleisner KS (2009) Evaluation of quantitative planar 90Y bremsstrahlung whole-body imaging. Phys Med Biol 54: 5873–5883.D. MinarikM. LjungbergP. SegarsKS Gleisner2009Evaluation of quantitative planar 90Y bremsstrahlung whole-body imaging.Phys Med Biol5458735883
- 7. Shen S, DeNardo GL, Yuan A, DeNardo DA, DeNardo SJ (1994) Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung. J Nucl Med 35: 1381–1389.S. ShenGL DeNardoA. YuanDA DeNardoSJ DeNardo1994Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung.J Nucl Med3513811389
- 8. Ho S, Lau WY, Leung TW, Chan M, Chan KW, et al. (1997) Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin. Br J Radiol 70: 823–828.S. HoWY LauTW LeungM. ChanKW Chan1997Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin.Br J Radiol70823828
- 9. Ho S, Lau WY, Leung TW, Chan M, Johnson PJ, et al. (1997) Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med 24: 293–298.S. HoWY LauTW LeungM. ChanPJ Johnson1997Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer.Eur J Nucl Med24293298
- 10. Bult W, Vente MAD, Zonnenberg BA, van het Schip AD, Nijsen JFW (2009) Microsphere, radioembolization of liver malignancies: current developments. Quarterly Journal of Nuclear Medicine and Molecular Imaging 53: 325–335.W. BultMAD VenteBA ZonnenbergAD van het SchipJFW Nijsen2009Microsphere, radioembolization of liver malignancies: current developments.Quarterly Journal of Nuclear Medicine and Molecular Imaging53325335
- 11. Koch W, Tatsch K (2008) Nuclear medicine procedures for treatment evaluation. In: Bilbao JI, Reiser MF, editors. Liver radioembolization with 90Y microspheres. Heidelberg: Springer. pp. 75–91.W. KochK. Tatsch2008Nuclear medicine procedures for treatment evaluation.JI BilbaoMF ReiserLiver radioembolization with 90Y microspheresHeidelbergSpringer7591
- 12. Sabet A, Ahmadzadehfar H, Muckle M, Haslerud T, Wilhelm K, et al. (2011) Significance of Oral Administration of Sodium Perchlorate in Planning Liver-Directed Radioembolization. Journal of Nuclear Medicine 52: 1063–1067.A. SabetH. AhmadzadehfarM. MuckleT. HaslerudK. Wilhelm2011Significance of Oral Administration of Sodium Perchlorate in Planning Liver-Directed Radioembolization.Journal of Nuclear Medicine5210631067
- 13. Salem R, Parikh P, Atassi B, Lewandowski RJ, Ryu RK, et al. (2008) Incidence of Radiation Pneumonitis After Hepatic Intra-Arterial Radiotherapy With Yttrium-90 Microspheres Assuming Uniform Lung Distribution. American Journal of Clinical Oncology-Cancer Clinical Trials 31: 431–438.R. SalemP. ParikhB. AtassiRJ LewandowskiRK Ryu2008Incidence of Radiation Pneumonitis After Hepatic Intra-Arterial Radiotherapy With Yttrium-90 Microspheres Assuming Uniform Lung Distribution.American Journal of Clinical Oncology-Cancer Clinical Trials31431438
- 14. Nijsen JF, Zonnenberg BA, Woittiez JR, Rook DW, Swildens-van Woudenberg IA, et al. (1999) Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: effects of preparation and neutron activation techniques. Eur J Nucl Med 26: 699–704.JF NijsenBA ZonnenbergJR WoittiezDW RookIA Swildens-van Woudenberg1999Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: effects of preparation and neutron activation techniques.Eur J Nucl Med26699704
- 15. Nijsen JF, Seppenwoolde JH, Havenith T, Bos C, Bakker CJ, et al. (2004) Liver tumors: MR imaging of radioactive holmium microspheres–phantom and rabbit study. Radiology 231: 491–499.JF NijsenJH SeppenwooldeT. HavenithC. BosCJ Bakker2004Liver tumors: MR imaging of radioactive holmium microspheres–phantom and rabbit study.Radiology231491499
- 16. Smits MLJ, Nijsen JFW, van den Bosch MAAJ, Lam MGEH, Vente MAD, et al. (2010) Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial. Journal of Experimental & Clinical Cancer Research 29: MLJ SmitsJFW NijsenMAAJ van den BoschMGEH LamMAD Vente2010Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial.Journal of Experimental & Clinical Cancer Research29
- 17. Vente MA, Nijsen JF, de Wit TC, Seppenwoolde JH, Krijger GC, et al. (2008) Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(L-lactic acid) microspheres in healthy pigs. Eur J Nucl Med Mol Imaging 35: 1259–1271.MA VenteJF NijsenTC de WitJH SeppenwooldeGC Krijger2008Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(L-lactic acid) microspheres in healthy pigs.Eur J Nucl Med Mol Imaging3512591271
- 18. Vente MA, de Wit TC, van den Bosch MA, Bult W, Seevinck PR, et al. (2010) Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model. Eur Radiol 20: 862–869.MA VenteTC de WitMA van den BoschW. BultPR Seevinck2010Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model.Eur Radiol20862869
- 19. Bayouth JE, Macey DJ (1994) Quantitative imaging of holmium-166 with an Anger camera. Phys Med Biol 39: 265–279.JE BayouthDJ Macey1994Quantitative imaging of holmium-166 with an Anger camera.Phys Med Biol39265279
- 20. de Wit TC, Xiao J, Nijsen JF, van het Schip FD, Staelens SG, et al. (2006) Hybrid scatter correction applied to quantitative holmium-166 SPECT. Phys Med Biol 51: 4773–4787.TC de WitJ. XiaoJF NijsenFD van het SchipSG Staelens2006Hybrid scatter correction applied to quantitative holmium-166 SPECT.Phys Med Biol5147734787
- 21. National Electrical Manufacturers Association (2007) NEMA Standards Publication NU 1-2007: Performance Measurements of Gamma Cameras. Rosslyn, VA: National Electrical Manufacturers Association. National Electrical Manufacturers Association2007NEMA Standards Publication NU 1-2007: Performance Measurements of Gamma CamerasRosslyn, VANational Electrical Manufacturers Association
- 22. National Electrical Manufacturers Association (2007) NEMA Standards Publication NU 2-2007: Performance Measurements of Positron Emission Tomographs. Rosslyn, VA: National Electrical Manufacturers Association. National Electrical Manufacturers Association2007NEMA Standards Publication NU 2-2007: Performance Measurements of Positron Emission TomographsRosslyn, VANational Electrical Manufacturers Association
- 23. Knesaurek K, Machac J, Muzinic M, DaCosta M, Zhang Z, et al. (2010) Quantitative comparison of yttrium-90 (90Y)-microspheres and technetium-99m (99mTc)-macroaggregated albumin SPECT images for planning 90Y therapy of liver cancer. Technol Cancer Res Treat 9: 253–262.K. KnesaurekJ. MachacM. MuzinicM. DaCostaZ. Zhang2010Quantitative comparison of yttrium-90 (90Y)-microspheres and technetium-99m (99mTc)-macroaggregated albumin SPECT images for planning 90Y therapy of liver cancer.Technol Cancer Res Treat9253262
- 24. Mansberg R, Sorensen N, Mansberg V, Van der Wall H (2007) Yttrium 90 Bremsstrahlung SPECT/CT scan demonstrating areas of tracer/tumour uptake. Eur J Nucl Med Mol Imaging 34: 1887.R. MansbergN. SorensenV. MansbergH. Van der Wall2007Yttrium 90 Bremsstrahlung SPECT/CT scan demonstrating areas of tracer/tumour uptake.Eur J Nucl Med Mol Imaging341887
- 25. Clarke LP, Cullom SJ, Shaw R, Reece C, Penney BC, et al. (1992) Bremsstrahlung Imaging Using the Gamma-Camera - Factors Affecting Attenuation. Journal of Nuclear Medicine 33: 161–166.LP ClarkeSJ CullomR. ShawC. ReeceBC Penney1992Bremsstrahlung Imaging Using the Gamma-Camera - Factors Affecting Attenuation.Journal of Nuclear Medicine33161166
- 26. Flamen P, Vanderlinden B, Delatte P, Ghanem G, Ameye L, et al. (2008) Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres. Phys Med Biol 53: 6591–6603.P. FlamenB. VanderlindenP. DelatteG. GhanemL. Ameye2008Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres.Phys Med Biol5365916603
- 27. Ito S, Kurosawa H, Kasahara H, Teraoka S, Ariga E, et al. (2009) (90)Y bremsstrahlung emission computed tomography using gamma cameras. Annals of Nuclear Medicine 23: 257–267.S. ItoH. KurosawaH. KasaharaS. TeraokaE. Ariga2009(90)Y bremsstrahlung emission computed tomography using gamma cameras.Annals of Nuclear Medicine23257267
- 28. Sorensen JA (1975) Deadtime characteristics of anger cameras. J Nucl Med 16: 284–288.JA Sorensen1975Deadtime characteristics of anger cameras.J Nucl Med16284288
- 29. Hendricks JS, McKinney GW, Waters LS, Roberts TS, Egdorf HW, et al. (2005) MCNPX Extensions, Version 2.5.0. Los Alamos, CA: Los Alamos National Laboratory Report LA-UR-05-2675. JS HendricksGW McKinneyLS WatersTS RobertsHW Egdorf2005MCNPX Extensions, Version 2.5.0Los Alamos, CALos Alamos National Laboratory Report LA-UR-05-2675
- 30. Rault E, Staelens S, Van Holen R, De Beenhouwer J, Vandenberghe S (2010) Fast simulation of yttrium-90 bremsstrahlung photons with GATE. Med Phys 37: 2943–2950.E. RaultS. StaelensR. Van HolenJ. De BeenhouwerS. Vandenberghe2010Fast simulation of yttrium-90 bremsstrahlung photons with GATE.Med Phys3729432950
- 31. Da Silva AJ, Tang HR, Wong KH, Wu MC, Dae MW, et al. (2001) Absolute Quantification of Regional Myocardial Uptake of 99mTc-Sestamibi with SPECT: Experimental Validation in a Porcine Model. J Nucl Med 42: 772–779.AJ Da SilvaHR TangKH WongMC WuMW Dae2001Absolute Quantification of Regional Myocardial Uptake of 99mTc-Sestamibi with SPECT: Experimental Validation in a Porcine Model.J Nucl Med42772779
- 32. Shcherbinin S, Celler A, Belhocine T, Vanderwerf R, Driedger A (2008) Accuracy of quantitative reconstructions in SPECT/CT imaging. Physics in Medicine and Biology 53: 4595–4604.S. ShcherbininA. CellerT. BelhocineR. VanderwerfA. Driedger2008Accuracy of quantitative reconstructions in SPECT/CT imaging.Physics in Medicine and Biology5345954604
- 33. Vandervoort E, Celler A, Harrop R (2007) Implementation of an iterative scatter correction, the influence of attenuation map quality and their effect on absolute quantitation in SPECT. Physics in Medicine and Biology 52: 1527–1545.E. VandervoortA. CellerR. Harrop2007Implementation of an iterative scatter correction, the influence of attenuation map quality and their effect on absolute quantitation in SPECT.Physics in Medicine and Biology5215271545
- 34. Zeintl J, Vija AH, Yahil A, Hornegger J, Kuwert T (2010) Quantitative Accuracy of Clinical 99mTc SPECT/CT Using Ordered-Subset Expectation Maximization with 3-Dimensional Resolution Recovery, Attenuation, and Scatter Correction. J Nucl Med 51: 921–928.J. ZeintlAH VijaA. YahilJ. HorneggerT. Kuwert2010Quantitative Accuracy of Clinical 99mTc SPECT/CT Using Ordered-Subset Expectation Maximization with 3-Dimensional Resolution Recovery, Attenuation, and Scatter Correction.J Nucl Med51921928
- 35. Gates VL, Esmail AAH, Marshall K, Spies S, Salem R (2011) Internal Pair Production of (90)Y Permits Hepatic Localization of Microspheres Using Routine PET: Proof of Concept. Journal of Nuclear Medicine 52: 72–76.VL GatesAAH EsmailK. MarshallS. SpiesR. Salem2011Internal Pair Production of (90)Y Permits Hepatic Localization of Microspheres Using Routine PET: Proof of Concept.Journal of Nuclear Medicine527276
- 36. Walrand S, Jamar F, van Elmbt L, Lhommel R, Bekonde EB, et al. (2010) 4-Step Renal Dosimetry Dependent on Cortex Geometry Applied to (90)Y Peptide Receptor Radiotherapy: Evaluation Using a Fillable Kidney Phantom Imaged by (90)Y PET. Journal of Nuclear Medicine 51: 1969–1973.S. WalrandF. JamarL. van ElmbtR. LhommelEB Bekonde20104-Step Renal Dosimetry Dependent on Cortex Geometry Applied to (90)Y Peptide Receptor Radiotherapy: Evaluation Using a Fillable Kidney Phantom Imaged by (90)Y PET.Journal of Nuclear Medicine5119691973
- 37. Lhommel R, van Elmbt L, Goffette P, Van den Eynde M, Jamar F, et al. (2010) Feasibility of (90)Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres. European Journal of Nuclear Medicine and Molecular Imaging 37: 1654–1662.R. LhommelL. van ElmbtP. GoffetteM. Van den EyndeF. Jamar2010Feasibility of (90)Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres.European Journal of Nuclear Medicine and Molecular Imaging3716541662
- 38. Lhommel R, Goffette P, Van den Eynde M, Jamar F, Pauwels S, et al. (2009) Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT. European Journal of Nuclear Medicine and Molecular Imaging 36: 1696–1696.R. LhommelP. GoffetteM. Van den EyndeF. JamarS. Pauwels2009Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT.European Journal of Nuclear Medicine and Molecular Imaging3616961696
- 39. Seevinck PR, Seppenwoolde JH, Zwanenburg JJ, Nijsen JF, Bakker CJ (2008) FID sampling superior to spin-echo sampling for T2*-based quantification of holmium-loaded microspheres: theory and experiment. Magn Reson Med 60: 1466–1476.PR SeevinckJH SeppenwooldeJJ ZwanenburgJF NijsenCJ Bakker2008FID sampling superior to spin-echo sampling for T2*-based quantification of holmium-loaded microspheres: theory and experiment.Magn Reson Med6014661476
- 40. Seppenwoolde JH, Nijsen JF, Bartels LW, Zielhuis SW, van het Schip AD, et al. (2005) Internal radiation therapy of liver tumors: qualitative and quantitative magnetic resonance imaging of the biodistribution of holmium-loaded microspheres in animal models. Magn Reson Med 53: 76–84.JH SeppenwooldeJF NijsenLW BartelsSW ZielhuisAD van het Schip2005Internal radiation therapy of liver tumors: qualitative and quantitative magnetic resonance imaging of the biodistribution of holmium-loaded microspheres in animal models.Magn Reson Med537684